CD4 and chronic kidney disease: Our data indicate for the first that the numbers of CD4+ regulatory T cells from PBMCs of CKD patients declined, even though the percentages of lymphocytes and CD4+ T cells were sustained at the same levels like that in PBMCs from normal subjects.